VivoSim Labs (VIVS) Return on Sales [ROS] (2011 - 2026)
VivoSim Labs' Return on Sales [ROS] was -15327.78% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 7449.40 percentage points from -7878.38% a year earlier and down 7360.28 percentage points from the prior quarter.
VivoSim Labs (VIVS) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, VivoSim Labs' Return on Sales [ROS] was -10116.96% through Jun 30, 2026, down 1564.15 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -8768.70%, down 7.59 percentage points from FY2025.
- Return on Sales [ROS] shows a four-year change of -8003.44 percentage points (FY2022 to FY2026).
- In earlier fiscal years, Return on Sales [ROS] was -8761.11% in FY2025 (+5079.26 pp), -13840.37% in FY2024 (-9048.20 pp), -4792.16% in FY2023 (-4026.90 pp) and -765.27% in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Sales [ROS] since fiscal Q3 2024.
- Compared with a year earlier, Return on Sales [ROS] was higher in four of the last eight quarters, with an average year-over-year change of +6869.97 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q3 2025 (a gain of 59150.00 percentage points); the worst was fiscal Q3 2024 (a drop of 71035.88 percentage points).
- Per Business Quant data, VIVS's Return on Sales [ROS] in the three fiscal quarters before Q1 2027 was -7967.50% (Q4 2026), -10576.92% (Q3 2026) and -9410.71% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 46.32 Bn | 38.02 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 18.64 Bn | 16.29 Bn | 223.89 Mn | 23.12% |
| 3 | Charles River Laboratories International | 16.55 Bn | 15.75 Bn | 363.37 Mn | 11.94% |
| 4 | Icon | 14.51 Bn | 11.62 Bn | 479.29 Mn | 6.68% |
| 5 | Fortrea Holdings | 2.23 Bn | 1.61 Bn | 139.20 Mn | 2.18% |
| 6 | Ginkgo Bioworks Holdings | 615.67 Mn | -146.42 Mn | 18.44 Mn | -290.47% |
| 7 | Evotec SE | 539.84 Mn | -1.07 Bn | - | - |
| 8 | Champions Oncology | 65.46 Mn | 40.54 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 53.84 Mn | 17.49 Mn | 1.61 Mn | -159.86% |
| 10 | VivoSim Labs | 778,584.04 | -16.95 Mn | - | -15,327.78% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,327.78% |
| Mar 31, 2026 | -7,967.50% |
| Dec 31, 2025 | -10,576.92% |
| Sep 30, 2025 | -9,410.71% |
| Jun 30, 2025 | -7,878.38% |
| Mar 31, 2025 | -6,184.31% |
| Dec 31, 2024 | -14,450.00% |
| Sep 30, 2024 | -8,693.33% |
| Jun 30, 2024 | -8,682.05% |
| Mar 31, 2024 | -10,675.86% |
| Dec 31, 2023 | -73,600.00% |
| Sep 30, 2023 | -5,284.78% |
| Jun 30, 2023 | -5,593.33% |
| Mar 31, 2023 | -4,801.85% |
| Dec 31, 2022 | -2,564.12% |
| Sep 30, 2022 | -4,355.84% |
| Jun 30, 2022 | -810.60% |
| Mar 31, 2022 | -127.53% |
| Sep 30, 2020 | -6,665.44% |
| Jun 30, 2020 | -1,160.99% |
VivoSim Labs Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VIVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VIVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VIVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();